Clinical Trials Sponsored by Institut fuer Frauengesundheit

Total 89 results

Institut fuer Frauengesundheit
Eisai GmbH

Recruiting

Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)

Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, Breast

Germany
Institut fuer Frauengesundheit
Novartis; ClinSol

Unknown

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) (PreFace)

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

Germany
Institut fuer Frauengesundheit
Samsung Bioepis Co., Ltd.

Recruiting

Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) (NeoON)

Breast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Female

Germany
Institut fuer Frauengesundheit
Merck Sharp & Dohme LLC

Recruiting

Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (COMPRENDO)

Breast Cancer | Malignant Neoplasm of Breast

Germany
Institut fuer Frauengesundheit
GlaxoSmithKline; Schantl Pharma Service, Germany

Unknown

Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma (AGO-Zervix-1)

Recurrent, Persistent or Metastasized Cervical Cancer

Germany
Institut fuer Frauengesundheit
Novartis Pharmaceuticals; AGO Breast Study Group e.V.

Recruiting

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer (CLEAR-B)

Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer

Germany
Institut fuer Frauengesundheit
Merck Sharp & Dohme LLC; Celgene Corporation

Completed

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NIB)

Malignant Neoplasm of Breast

Germany
Institut fuer Frauengesundheit
Novartis Pharmaceuticals; AGO Breast Study Group e.V.

Recruiting

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients (CAPTOR-BC)

Breast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

Germany
Onco Medical Consult GmbH
Eli Lilly and Company; Institut fuer Frauengesundheit

Unknown

Implementing Patients´ Competence in Oral Breast Cancer Therapy (IMPACT)

Advanced Breast Cancer | Metastatic Breast Cancer
Stiftung Institut fuer Herzinfarktforschung

Active, not recruiting

The German Plug - Registry (PLUG)

Heart Valve Replacement

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

Chest Pain Unit II Register

Chest Pain

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

German TAVI-Register (TAVI)

Aortic Valve Stenosis | Aortic Valve Insufficiency

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

Aortic-Stent-Register

Aortic Dissection

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

LASER: Real Life Antithrombotic Stent Evaluation Registry (LASER)

Percutaneous Coronary Intervention

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

German Ablation Quality-Register

Arrhythmia

Germany
Stiftung Institut fuer Herzinfarktforschung

Recruiting

CArdioSurgEry Atrial Fibrillation Register (CASE-AF)

Atrial Fibrillation

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

ARENA - Project Atrial Fibrilation Rhine-Neckar Region (ARENA)

Atrial Fibrillation

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

Left-Atrium-Appendage Occluder Register - GErmany (LAARGE)

Stroke | Atrial Fibrillation

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

Cardiogoniometry for Early Diagnosis of Coronary Artery Disease Symptomatik

Stable Angina Pectoris
Stiftung Institut fuer Herzinfarktforschung

Completed

European Cardio Computer Tomography Registry

Consecutive Patients Undergoing Computed Tomography of the Heart for Clinical Indications

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

Deutsches Device Qualitätsregister

Heart Failure

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

German Chest Pain Unit (CPU)-Register

Chest Pain

Germany
Stiftung Institut fuer Herzinfarktforschung

Completed

Cardiogoniometry (CGM) for Early Diagnosis of Acute Coronary Syndromes (ACS) (CGM@ACS)

Chest Pain
Stiftung Institut fuer Herzinfarktforschung

Completed

European CMR Registry

Consecutive Patients Undergoing CMR

Switzerland, Spain, Germany, Italy
Stiftung Institut fuer Herzinfarktforschung
Medtronic

Completed

FREEZE Cohort Study

Arrhythmia

Germany, United States, Austria, Greece, South Africa, Spain
Stiftung Institut fuer Herzinfarktforschung
Vifor Pharma

Completed

EVIdence Based TreAtment - Heart Failure (EVITA-HF) (EVITA-HF)

Heart Failure

Germany
Stiftung Institut fuer Herzinfarktforschung
Impulse Dynamics

Completed

Effects of CCM-therapy in Patients With Heart Failure (CCM-HF)

Heart Failure

Germany
Stiftung Institut fuer Herzinfarktforschung
Novartis Pharmaceuticals

Completed

Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany (3A)

Arterial Hypertension
Stiftung Institut fuer Herzinfarktforschung
Boston Scientific Corporation

Completed

MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology (MIFI)

Atrial Flutter
University of Leipzig
Stiftung Institut fuer Herzinfarktforschung

Withdrawn

ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI) (IDEAL NSTEMI)

Non-ST-elevation Myocardial Infarction

Germany
Stiftung Institut fuer Herzinfarktforschung
Daiichi Sankyo, Inc.

Completed

Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI (ETAMI)

Myocardial Infarction | STEMI

France, Germany
Institut fuer anwendungsorientierte Forschung und...

Completed

A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas (escZ-BEAM)

Primary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's Lymphoma

Germany
Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie...

Completed

Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Austria
Stiftung Institut fuer Herzinfarktforschung
Sanofi-Aventis Deutschland GmbH

Completed

Sweetheart-Register: Risk Management of Diabetics With Acute Myocardial Infarction (Sweetheart)

Myocardial Infarction | Diabetes | STEMI | NSTEMI

Germany
metaX Institut fuer Diatetik GmbH
Birmingham Children's Hospital

Completed

Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria

Phenylketonurias | Hyperphenylalaninaemia | Tetrahydrobiopterin Deficiency

United Kingdom
Institut fuer anwendungsorientierte Forschung und...

Completed

Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring

Stroke

Germany
Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie...

Completed

Effects of a Rehabilitation Program on Immune Activation and Mood in Heart Failure Patients

Heart Failure | Depressive Symptoms

Austria
Institut fuer anwendungsorientierte Forschung und...

Completed

Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

Alcohol Drinking | Alcoholism | Alcohol Consumption | Alcohol Abuse | Alcohol Relapse Prevention

Germany
Institut fuer anwendungsorientierte Forschung und...

Completed

Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics

Membrane Transport | Drug Biotransformation

Germany
Institut fuer anwendungsorientierte Forschung und...

Completed

Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

Optic Neuritis

Germany
Stiftung Institut fuer Herzinfarktforschung
Bristol-Myers Squibb; Sanofi

Completed

CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction

Myocardial Infarction

Germany, Austria
Stiftung Institut fuer Herzinfarktforschung
Pronova BioPharma; Trommsdorff GmbH & Co. KG

Completed

OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction (OMEGA)

Myocardial Infarction

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM VGM77

Diabetes

Germany
Institut fur Diabetesforschung, Munich, Germany

Unknown

PINGUIN (Postpartum Intervention in Women With Gestational Diabetes Using Insulin)

Insulin-dependent Gestational Diabetes

Germany
Institut fur Diabetesforschung, Munich, Germany

Unknown

BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk

Type 1 Diabetes

Germany
cerbomed GmbH
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Completed

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia (02VNS2009)

Schizophrenia

Germany
Stiftung Institut fuer Herzinfarktforschung
GlaxoSmithKline; University Hospital Muenster; Klinikum Nürnberg

Completed

OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry (OPTAMI)

Myocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial Infarction

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM JS200B

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Enrolling by invitation

System Accuracy of 14 Blood Glucose Monitoring Systems

Diabetes

Germany
Institut fur Diabetesforschung, Munich, Germany

Completed

Immunointervention With Calcitriol in New-Onset Type 1 Diabetes

Type 1 Diabetes

Germany

Clinical Trials Sponsored by Institut fuer Frauengesundheit

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations